Surrozen, Inc./DE
10-K
March 23, 2026
Key Highlights
- Pioneering Wnt pathway technology (SWAP) for tissue repair and regeneration, foc...
- Strong partnership with Boehringer Ingelheim for SZN-413, providing significant ...
- Wholly-owned drug candidates (SZN-8141, SZN-8143) with multi-pronged approaches ...
Read Analysis
🤖 AI Generated